![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Next generation core inhibitors ABI-H3733 and ABI-4334 have significantly improved potency and target WED-114 coverage for both antiviral and cccDNA formation activities compared to first-generation core inhibitors
|
|
|
EASL 2023 June 21-24 Vienna
Nuruddin Unchwaniwala, Katie Zomorodi, Michael Shen, Ran Yan, Ariel Tang, Xiang Xu, Michel Perron, William Delaney, Kathryn M. Kitrinos
Assembly Biosciences, Inc., South San Francisco, CA, USA
![0703231](../images/070323/070323-13/0703231.gif)
![0703232](../images/070323/070323-13/0703232.gif)
![0703233](../images/070323/070323-13/0703233.gif)
![0703234](../images/070323/070323-13/0703234.gif)
![0703235](../images/070323/070323-13/0703235.gif)
![0703236](../images/070323/070323-13/0703236.gif)
![0703237](../images/070323/070323-13/0703237.gif)
![0703238](../images/070323/070323-13/0703238.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|